|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/62 | (2006.01) |
| A61K 38/28 | (2006.01) | ||
| C12N 15/62 | (2006.01) |
| (11) | Number of the document | 3292141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16721605.0 |
| Date of filing the European patent application | 2016-04-28 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation | 2020-03-25 |
| (86) | Number | PCT/US2016/029807 |
| Date | 2016-04-28 |
| (87) | Number | WO 2016/178905 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 201562158079 P | 2015-05-07 | US |
| (72) |
BALDWIN, David Bruce, US
BEALS, John Michael, US
DAY, Jonathan Wesley, US
DICKINSON, Craig Duane, US
KORYTKO, Andrew Ihor, US
LAZAR, Gregory Alan, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Sulieti baltymai |
| FUSION PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 11 | 289.00 EUR |
| 2027-04-28 |